2Kuerer HM, Newman LA, Buzdar AU, et al. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status [J]. Cancer J Sci Am,1998,4(4):230-236.
3Pierga JY, Mouret E, Dieras V, et al. Prognostic value of persistent node involvement after neroadjuvant chemotherapy in patients with operable breast cancer [J]. Br J Cancer,2000,83(11): 1 480-1 487.
4Recht A. Locally advanced breast cancer and postmastectomy radiotherapy[J]. Surg Oncol Clin Am,2000,9(3):603-620.
1[1]FISHER B, SAFFET E A, RUDOCK C,et al. Effect of local or systemic treatment prior to primary tumour removal on the production and response to a serum growth stimulating factor in mice[J]. Cancer Res ,1989,49:2002
2[2]GOLDMAN J H,COLDMAN A J. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate[J].Cancer Treat Rep, 1979,63:1727
3[3]KOSCIELNY S, TUBIANA M, LE M G,et al. Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination[J]. Br J Cancer ,1984, 49:709
4[4]HAYWARD J L, CARBONE P P, HEUSON J C, et al. Assessment of response to therapy in advanced breast cancer[J]. Br J Cancer ,1997,35:292
5[5]CAYRE A, CACHIN F, MAUBLANT J,et al.Single static view 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression[J]. Int J Oncol ,2002,20(5):1049
6[6]VAN DER HAGE J A, VAN DER VELDER C J H, JUAIEN J P,et al. Preoperative chemotherapy in primary operable breast cancer:results from the european organization for research and treatment of cancer trial 10902[J]. J Clin Oncol ,2001,19(22):4224
7[7]FISHER B,BRYANT J, WOLMARK N. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer[J]. J Clin Oncol, 1998,16(8):2672
8[8]MAMOUNAS E P. NSABP Protocol B-27. Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel[J]. Oncology (Huntingt) ,1997,11(6 Suppl 6):37
9[9]MAMOUNAS E P, FISHER B. Preoperative (Neoadjuvant) chemotherapy in patients with breast cancer[J]. Seminars in Oncol ,2001,28(4):389
10[10]THAMAS E, BUZDAR A, THERIAULT R, et al. Role of paclitaxel in adjuvant therapy of operable breast cancer: preliminary results of prospective randomized clinical trial[J]. Proc Am Soc Clin Oncol, 2000,19(74): 285
